Phase 3 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with a primary indeterminate lesion or small choroidal melanoma (a type of eye tumour) (confirm with trial site)
- People whose imaging results show no signs that the condition has spread to other parts of the body
- People who have not previously received treatment for their indeterminate lesion or small choroidal melanoma, although those who have had a treatment called PDT (photodynamic therapy) may still be eligible
Who may not be able to join:
- People who have known allergies, sensitivities, or medical reasons why they cannot receive the study drug or the laser used in the trial
- People who currently have an active infection or disease affecting the eye
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Monitor, Aura Biosciences
Phone: 617-500-8864
Australian sites
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Time to reach tumor progression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.